WallStreetZenWallStreetZen

NASDAQ: MRNA
Moderna Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MRNA

Based on 7 analysts offering 12 month price targets for Moderna Inc.
Min Forecast
$86.00-15.69%
Avg Forecast
$127.14+24.65%
Max Forecast
$231.00+126.47%

Should I buy or sell MRNA stock?

Based on 7 analysts offering ratings for Moderna Inc.
Buy
Strong Buy
2 analysts 28.57%
Buy
2 analysts 28.57%
Hold
2 analysts 28.57%
Sell
1 analysts 14.29%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MRNA stock forecasts and price targets.

MRNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-09
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-02-26
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2024-01-02
JP Morgan
Top 12%
89
HoldMaintains$90.00-11.76%2023-12-01
Goldman Sachs
Top 30%
71
Strong BuyMaintains$231.00+126.47%2023-11-03

1 of 1

Forecast return on equity

Is MRNA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.66%

Forecast return on assets

Is MRNA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MRNA revenue forecast

What is MRNA's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$4.2B-39.27%
Avg 2 year Forecast
$5.1B-24.82%
Avg 3 year Forecast
$7.7B+12.66%
MRNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MRNA revenue growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
1.99%
Industry
37.96%
Market
10.23%
MRNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MRNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MRNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MRNA$102.00$127.14+24.65%Buy
ARGX$358.41$511.67+42.76%Strong Buy
BNTX$86.17$114.71+33.13%Hold
GMAB$28.33$45.00+58.84%Buy
ALNY$145.16$213.58+47.14%Buy
View Top Biotech Stocks

Moderna Stock Forecast FAQ

Is Moderna Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: MRNA) stock is to Buy MRNA stock.

Out of 7 analysts, 2 (28.57%) are recommending MRNA as a Strong Buy, 2 (28.57%) are recommending MRNA as a Buy, 2 (28.57%) are recommending MRNA as a Hold, 1 (14.29%) are recommending MRNA as a Sell, and 0 (0%) are recommending MRNA as a Strong Sell.

If you're new to stock investing, here's how to buy Moderna stock.

What is MRNA's revenue growth forecast for 2024-2026?

(NASDAQ: MRNA) Moderna's forecast annual revenue growth rate of 1.99% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Moderna's revenue in 2024 is $6,848,000,000.On average, 10 Wall Street analysts forecast MRNA's revenue for 2024 to be $1,589,015,344,874, with the lowest MRNA revenue forecast at $1,425,285,895,123, and the highest MRNA revenue forecast at $1,808,963,810,597. On average, 10 Wall Street analysts forecast MRNA's revenue for 2025 to be $1,967,158,547,857, with the lowest MRNA revenue forecast at $1,549,857,043,860, and the highest MRNA revenue forecast at $2,776,182,136,649.

In 2026, MRNA is forecast to generate $2,947,760,516,312 in revenue, with the lowest revenue forecast at $1,499,602,954,811 and the highest revenue forecast at $6,130,173,585,756.

What is MRNA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MRNA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MRNA's Price Target?

According to 7 Wall Street analysts that have issued a 1 year MRNA price target, the average MRNA price target is $127.14, with the highest MRNA stock price forecast at $231.00 and the lowest MRNA stock price forecast at $86.00.

On average, Wall Street analysts predict that Moderna's share price could reach $127.14 by Apr 9, 2025. The average Moderna stock price prediction forecasts a potential upside of 24.65% from the current MRNA share price of $102.00.

What is MRNA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MRNA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.